Pathogenicmonogenic mutations in genes such as SNCA, LRRK2, and PARK2 are associatedwith familial forms of PD and may serve as biomarkers for genetictesting and personalized risk assessment. The gene discussed is PRKN; the disease is Parkinson disease.